Managers / Q2 2023 · view latest →
Vazirani Asset Management LLC
CIK 0001716476 · 1540 BROADWAY, SUITE 1600, NEW YORK, NY, 10036 · 646-504-4181
Summary
Vazirani Asset Management LLC reported $59M in U.S.-listed holdings across 28 positions for Q2 2023.
Its largest position, Univar Solutions, represents 14.0% of the portfolio.
Compared with Q1 2023, the fund opened 16 new positions and exited 10.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 83.3% · $49M
- Other · 16.1% · $10M
- ADR · 0.6% · $359,300
Quarter-over-Quarter Changes full breakdown →
vs Q1 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| FRANCHISE GROUP INC | NEW | +250.0K | 250.0K | +$7M | $7M |
| IVERIC BIO INC | NEW | +180.0K | 180.0K | +$7M | $7M |
| SEAGEN INC | NEW | +25.0K | 25.0K | +$5M | $5M |
| AMC ENTERTAINMENT HLDS-CL A | NEW | +6.6K | 6.6K | +$2M | $2M |
| ARLINGTON ASSET INVST CORP | NEW | +350.4K | 350.4K | +$2M | $2M |
| BLUBELLUS HEALTH INC NEW | NEW | +109.6K | 109.6K | +$2M | $2M |
| VMWARE INC | NEW | +10.0K | 10.0K | +$1M | $1M |
| DICE THERAPEUTICS INC | NEW | +30.0K | 30.0K | +$1M | $1M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2023
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | UNIVAR SOLUTIONS INC | COM | 14.02% | $8M | 232.0K |
| 2 | LIFE STORAGE INC | COM | 12.33% | $7M | 55.0K |
| 3 | FRANCHISE GROUP INC | COM | 12.07% | $7M | 250.0K |
| 4 | IVERIC BIO INC | COM | 11.94% | $7M | 180.0K |
| 5 | NATIONAL INSTRS CORP | COM | 9.68% | $6M | 100.0K |
| 6 | SEAGEN INC | COM | 8.11% | $5M | 25.0K |
| 7 | HORIZON THERAPEUTICS PUB L | SHS | 6.94% | $4M | 40.0K |
| 8 | ACTIVISION BLIZZARD INC | COM | 3.55% | $2M | 25.0K |
| 9 | TSEMTOWER SEMICONDUCTOR LTDhistory → | SHS NEW | 3.16% | $2M | 50.0K |
| 10 | ARLINGTON ASSET INVST CORP | CL A NEW | 2.74% | $2M | 350.4K |
| 11 | BLUBELLUS HEALTH INC NEWhistory → | COM NEW | 2.72% | $2M | 109.6K |
| 12 | VMWARE INC | CL A COM | 2.42% | $1M | 10.0K |
| 13 | DICE THERAPEUTICS INC | COM | 2.35% | $1M | 30.0K |
| 14 | MANCHESTER UTD PLC NEW | ORD CL A | 1.03% | $609,500 | 25.0K |
| 15 | CYTEIR THERAPEUTICS INC | COM | 0.68% | $405,951 | 156.1K |
| 16 | SIMOSILICON MOTION TECHNOLOGY CO | SPONSORED ADR | 0.61% | $359,300 | 5.0K |
| 17 | BLACK KNIGHT INC | COM | 0.50% | $298,650 | 5.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $43M | 20 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $16M | 10 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $28M | 13 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $26M | 17 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $27M | 15 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $32M | 19 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $56M | 29 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $47M | 25 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $36M | 18 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $24M | 22 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $65M | 26 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $59M | 28 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | Under review | 17 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | Under review | 24 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $93M | 37 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $77M | 30 | Aug 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $116M | 57 | May 5, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $87M | 51 | Feb 3, 2022 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.